Tag Archives: biotech

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) plunged into the close of 2016, and hasn’t been able to stage any degree of recovery throughout early 2017. The company fell foul of some negative data surrounding its lead asset in December,...

Bemax Inc (OTCMKTS:BMXC) has had a great start to 2017. The company closed out last year trading for just $0.006 a share. Fast forward to the end of last week, and this had risen to $0.017 a share. It’s still a microcap, but the close...

Opexa Therapeutics Inc (NASDAQ:OPXA) ran up towards the end of last week on a spike in volume, despite a lack of any clear catalysts. The company has been something of a dead entity for the last couple of months, having put out data from its...

We’re always on the lookout for biotech runners, and one that’s impossible to overlook right now is Transgenomic Inc (NASDAQ:TBIO). The company gained close to 300% on Thursday, and looks set to continue its run into the end of...

Dextera Surgical Inc (NASDAQ:DXTR) is up more than 120% so far this week, on a corporate update put out by management to address the fiscal 2017 sales of its lead asset. If the numbers outlined in the update can be hit, and based on the numbers...

When Rennova Health Inc (NASDAQ:RNVA) announced mid December that it was pricing a public offering, the company took a considerable hit. Throughout the latter half of the month, and into early 2017, this decline continued. Late this week, however,...

Genocea Biosciences Inc (NASDAQ:GNCA) found itself on the wrong side of an Adam Feuerstein Tweet back in March, 2016, when the latter highlighted an interim release as being baseless from an efficacy perspective, rooted in the fact that the...

Low floats have been the name of the game for a number of biotech companies this week, with some seemingly inexplicable runs only explained by low float, high-volume spikes. Here is another one. The company is GenVec Inc (NASDAQ:GNVC), and...

ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) is one of the week’s biggest biotech runners, up close to 200% on the Monday open. At a glance, there doesn’t look to be too much we can pin the gains on – there has been no news...

Biocept Inc (NASDAQ:BIOC) gained more than 77% during Tuesday’s session this week, and is up more than 100% on last week’s close, on news that the company has picked up a fresh round of insurance coverage for its lead biopsy product....

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter

Sign Up Now For Our FREE Small Cap Newsletter